以上内容来自Benzinga Earnings专栏,原文如下:
BioLife Solns (NASDAQ:BLFS) reported quarterly sales of $22.71 million which beat the analyst consensus estimate of $21.55 million by 5.41 percent. This is a 30.61 percent decrease over sales of $32.73 million the same period last year.
精彩评论